Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Thomas HM Jr, Woods AC (1936) Progressive exophthalmos following thyroidectomy. Bull Hopkins Hosp 59:99–113
Jones A (1951) Orbital X-ray therapy of progressive exophthalmos. Br J Radiol 24:637–646
Beiewaltes WH (1951) Irradiation of the pituitary in the treatment of malignant exophthalmos. J Clin Endocrinal Metab 11:512–530
Beierwaltes WH (1953) X-ray treatment of malignant exophthalmos: a report on 28 patients. J Clin Endocrinol Metab 13:1090–1100
Gedda PO, Lindgren M (1954) Pituitary and orbital roentgen therapy in the hyperophthalmopathic type of Graves’ disease. Acta Radiol 42:211–220
Wijndbladh HJ, Mossberg H, Liungman S (1954) On exophthalmos and its treatment. Acta Endocrinol 17:442–451
Hermann K (1972) Pituitary exophthalmos: an assessment of methods of treatment. Br J Ophthalmol 36:1–19
Donaldson SS, Bagshaw MA, Kriss JP (1973) Supervoltage orbital radiotherapy for Graves’ ophthalmopathy. J Clin Endocrinol Metab 37:276–285
Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A (1991) Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 14:853–860
Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A (1991) Role of orbital radiotherapy in the treatment of Graves’ ophthalmopathy. Exp Clin Endocrinol 97:332–337
Kao SC, Kendler DL, Nugent RA, Adler JS, Rootman J (1993) Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes. Arch Ophthalmol 111:819–823
Petersen IA, Kriss JP, McDougall IR, Donaldson SS (1990) Prognostic factors in the radiotherapy of Graves’ ophthalmopathy. Int J Radiat Oncol Biol Phys 19:259–264
Kazim M, Trokel S, Moore S (1991) Treatment of acute Graves orbitopathy. Ophthalmology 98:1443–1448
Lloyd WC 3rd, Leone CR Jr (1992) Supervoltage orbital radiotherapy in 36 cases of Graves’ disease. Am J Ophthalmol 113:374–380
Mourits MP, van Kempen-Harteveld ML, Garcia MB, Koppeschaar HP, Tick L, Terwee CB (2000) Radiotherapy for Graves’ orbitopathy: randomised placebo-controlled study. Lancet 355:1505–1509
Prummel MF, Terwee CB, Gerding MN, et al. (2004) A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab 89:15–20
Gorman CA, Garrity JA, Fatourechi V, et al. (2001) A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves’ ophthalmopathy. Ophthalmology 108:1523–1534
Gorman CA, Garrity JA, Fatourechi V, et al. (2002) The aftermath of orbital radiotherapy for Graves’ ophthalmopathy. Ophthalmology 109:2100–2107
Robertson DM, Buettner H, Gorman CA, et al. (2003) Retinal microvascular abnormalities in patients treated with external radiation for Graves ophthalmopathy. Arch Ophthalmol 121:652–657
Wiersinga WM (2002) Perspective — part III: retrobulbar irradiation in Graves orbitopathy: the Dutch experience. Ophthal Plast Reconstr Surg 18:175–176
Kazim M (2002) Perspective — part II: radiotherapy for Graves orbitopathy: the Columbia University experience. Ophthal Plast Reconstr Surg 18:173–174
Bartley GB, Gorman CA (2002) Perspective — part I: the Mayo orbital radiotherapy for Graves ophthalmopathy (ORGO) study: lessons learned. Ophthal Plast Reconstr Surg 18:170–172
Trott KR, Kamprad F (1999) Radiobiological mechanisms of anti-inflammatory radiotherapy. Radiother Oncol 51:197–203
Marcocci C, Bartalena L, Rocchi R, et al. (2003) Long-term safety of orbital radiotherapy for Graves’ ophthalmopathy. J Clin Endocrinol Metab 88:3561–3566
Akmansu M, Dirican B, Bora H, Gurel O (2003) The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves’ orbitopathy. Ophthalmic Res 35:150–153
Snijders-Keilholz A, De Keizer RJ, Goslings BM, Van Dam EW, Jansen JT, Broerse JJ (1996) Probable risk of tumour induction after retro-orbital irradiation for Graves’ ophthalmopathy. Radiother Oncol 38:69–71
Schaefer U, Hesselmann S, Micke O, et al. (2002) A long-term follow-up study after retro-orbital irradiation for Graves’ ophthalmopathy. Int J Radiat Oncol Biol Phys 52:192–197
Wakelkamp IM, Tan H, Saeed P, et al. (2004) Orbital irradiation for Graves’ ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology 111:1557–1562
Just M, Kahaly G, Higer HP, et al. (1991) Graves ophthalmopathy: role of MR imaging in radiation therapy. Radiology 179:187–190
Gerding MN, van der Zant FM, van Royen EA, et al. (1999) Octreotide scintigraphy is a disease-activity parameter in Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 50:373–379
Ott M, Breiter N, Albrecht CF, Pradier O, Hess CF, Schmidberger H (2002) Can contrast enhanced MRI predict the response of Graves’ ophthalmopathy to orbital radiotherapy? Br J Radiol 75: 514–517
Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM (2001) The usefulness of quantitative orbital magnetic resonance imaging in Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 54:205–209
Terwee CB, Prummel MF, Gerding MN, Kahaly GJ, Dekker FW, Wiersinga WM (2005) Measuring disease activity to predict therapeutic outcome in Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 62:145–155
Kahaly GJ, Rosler HP, Pitz S, Hommel G (2000) Low-versus high-dose radiotherapy for Graves’ ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab 85:102–108
Gerling J, Kommerell G, Henne K, Laubenberger J, Schulte-Monting J, Fells P (2003) Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy. Int J Radiat Oncol Biol Phys 55:182–189
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kazim, M. (2006). The Role of Orbital Radiotherapy in the Management of Thyroid Related Orbitopathy. In: Guthoff, R., Katowitz, J.A. (eds) Oculoplastics and Orbit. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29969-6_8
Download citation
DOI: https://doi.org/10.1007/3-540-29969-6_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22599-7
Online ISBN: 978-3-540-29969-1
eBook Packages: MedicineMedicine (R0)